FdaApplication
NDA 219019
Identifiers
- fda_app_no: NDA219019
Properties
| Property | Value |
|---|---|
| applicant_name | GENZYME CORP |
| application_type | NDA |
| approval_date | 2025-03-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QFITLIA | FITUSIRAN SODIUM | EQ 50MG BASE/0.5ML (EQ 50MG BASE/0.5ML) | SOLUTION;SUBCUTANEOUS |
| QFITLIA | FITUSIRAN SODIUM | EQ 20MG BASE/0.2ML (EQ 20MG BASE/0.2ML) | SOLUTION;SUBCUTANEOUS |
2 products